Clinical Scorecard: Exploring the Effects of Metabolic and Bariatric Surgery on Psychosocial and Relationship Well-being: A Comprehensive Review
At a Glance
Category
Detail
Condition
Obesity, particularly class III obesity
Key Mechanisms
Pathological excess adipose tissue causing physiological dysfunction; multifactorial etiology including genetics, environment, and socioeconomic factors; psychosocial burden and psychiatric comorbidities
Target Population
Adults with BMI ≥ 35 kg/m² or BMI 30–34.9 kg/m² with metabolic disease; Asian populations with BMI ≥ 27.5 kg/m²
Care Setting
Specialist metabolic and bariatric surgery centers with integrated biopsychosocial follow-up
Key Highlights
Obesity is a chronic, multifactorial disease with significant physical and psychological comorbidities.
Metabolic and bariatric surgery (MBS) is the primary treatment for class III obesity, improving metabolic parameters and psychosocial well-being.
Psychiatric comorbidity is highly prevalent in MBS candidates, necessitating routine mental health screening and integrated care.
Guideline-Based Recommendations
Diagnosis
Use BMI to classify obesity: overweight (25.0–29.9 kg/m²), obesity class I (30.0–34.9 kg/m²), class II (35.0–39.9 kg/m²), class III (≥ 40 kg/m²).
Screen for psychiatric comorbidities including mood, anxiety, and binge-eating disorders using standardized mental health assessments preoperatively.
Management
Recommend MBS for adults with BMI ≥ 35 kg/m² regardless of comorbidities, and for BMI 30–34.9 kg/m² with metabolic disease; BMI threshold is ≥ 27.5 kg/m² in Asian populations.
Common surgical options include sleeve gastrectomy and Roux-en-Y gastric bypass; less invasive options like intragastric balloon and endoscopic sleeve gastroplasty may be considered.
Incorporate pharmacotherapy (e.g., GLP-1 receptor agonists) adjunctively with lifestyle modifications where appropriate.
Monitoring & Follow-up
Implement routine, standardized mental health screening at baseline and every postoperative visit.
Provide prompt referral to specialist mental health care as part of integrated biopsychosocial follow-up.
Risks
Psychiatric disorders may influence surgical outcomes and adherence; weight stigma and psychosocial burden can affect mental health.
Less invasive endoscopic procedures may have lower procedural risk but potentially less sustained weight loss.
Patient & Prescribing Data
Adults with class III obesity or metabolic disease at lower BMI thresholds
Pharmacotherapies such as semaglutide and tirzepatide induce significant weight loss (~15–21%) but are best combined with lifestyle changes; MBS remains primary for sustained weight loss and metabolic improvement.
Clinical Best Practices
Adopt a multidisciplinary approach integrating surgical, medical, and psychosocial care.
Conduct comprehensive preoperative mental health evaluations and ongoing postoperative psychosocial support.
Educate patients on potential psychosocial and relational changes following MBS to optimize satisfaction and adherence.
Consider patient-specific factors including psychiatric comorbidities and social support when planning treatment.
